<< Read Full Article
<< Read Full Article
Updated from 1:49 p.m. EDT
Widely held health care stocks were mixed Wednesday, with Bristol-Myers Squibb(BMY Quote) slipping on an analyst downgrade and earnings reports from two drugmakers.
Goldman Sachs downgraded Bristol from Buy to Neutral on Wednesday, citing relative valuation and the company's diminishing chances of getting taken over. Shares were recently down 2.6% to $19.14.
After falling earlier in the day, Pfizer(PFE Quote) was recently up 0.8% to $13.50, and Johnson & Johnson(JNJ Quote) was up 0.4% to $50.83. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,405.83 | 1,102.35 | 2,190.86 | 34.82 |
Oil *
71.98
|
|
UP
68.78
|
UP
6.41
|
UP
7.13
|
UP
0.59
|
10 Yr
3.48%
SPDR Gold
110.82
|
|
+0.67%
|
+0.58%
|
+0.33%
|
+1.72%
|
Data delayed 20 minutes |
Connect with TheStreet